Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics-based anticancer drug discovery and development.

K K Jain1

  • 1Jain PharmaBiotech, Blaesiring 7, CH-4057 Basel, Switzerland. jain@pharmabiotech.ch

Technology in Cancer Research & Treatment
|March 11, 2003
PubMed
Summary

Proteomic technologies aid cancer drug discovery by analyzing protein defects and interactions. These methods are crucial for identifying cancer biomarkers and developing personalized medicines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression and activity of key lipases during the larval development of walking catfish (Clarias magur).

Journal of experimental zoology. Part B, Molecular and developmental evolution·2019
Same author

Effects of dietary synbiotic on innate immunity, antioxidant activity and disease resistance of Cirrhinus mrigala juveniles.

Fish & shellfish immunology·2018
Same author

Personalized medicine conference.

Personalized medicine·2018
Same author

Haemato-biochemical, non-specific immunity, antioxidant capacity and histopathological changes in Labeo rohita fingerlings fed rubber protein isolate.

Fish physiology and biochemistry·2016
Same author

Dietary protein enhances non-specific immunity, anti-oxidative capability and resistance to Aeromonas hydrophila in Labeo rohita fingerlings pre-exposed to short feed deprivation stress.

Fish & shellfish immunology·2016
Same author

Future of nanomedicine: impact on healthcare & society.

Nanomedicine (London, England)·2015

Area of Science:

  • Biochemistry
  • Oncology
  • Proteomics

Background:

  • Malignancy involves defects in cellular protein machinery, making proteins key targets for cancer drug discovery.
  • Integrating proteomic and genomic approaches enhances cancer drug discovery and target validation.

Purpose of the Study:

  • To highlight the significance of proteomic technologies in cancer drug discovery.
  • To outline key proteomic methods and their applications in identifying cancer drug targets.

Main Methods:

  • Three-dimensional (3-D) protein structure determination
  • Protein microarrays
  • Laser capture microdissection
  • Analysis of protein-protein and protein-drug interactions

Main Results:

  • Proteomic technologies are vital for identifying cancer biomarkers and cellular pathways as drug targets.
  • Several companies are actively utilizing proteomic technologies for cancer drug development.

Conclusions:

  • Proteomic approaches are essential for advancing cancer drug discovery.
  • Proteomics will play a significant role in the development of personalized cancer medicines.

Related Experiment Videos